In a pre-clinical trial, Researchers at the National University of Ireland Galway have found that mesenchymal stem cells (MSCs) demonstrate the ability to increase wound healing for diabetics’ related wounds. Diabetic patients have impaired ability to heal wounds with 25% of diabetic patients affected by foot ulcers; which may result in amputation.
According to lead researcher Professor Timothy O’Brien, “MSC’s have many attractive therapeutic properties.” “They can be isolated from adults and are easy to grow in the laboratory. It has been shown in Galway, and by other scientists, that they release special factors that can help new blood vessels to grow. Increasing blood flow is a key step in wound healing.” As a result of their research, Dr. O’Brien and his associates hope to initiate clinical trials soon.
In addition to the wound healing capability of MSCs, they can also be differentiated into many types of tissue such as muscle, insulin producing pancreatic beta cells, cardiomyocites, neurons, bone and cartilage amongst them. These valuable and highly proliferative stem cells can be obtained from the dental pulp of baby teeth and wisdom teeth and cryopreserved for use in a broad array of future stem cell therapies. To learn more about how to bank your stem cells, visit www.stemsave.com or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The future of Regenerative Medicine is now™